BeiGene Ltd (BGNE)
194.76
+0.50
(+0.26%)
USD |
NASDAQ |
Nov 21, 16:00
194.76
0.00 (0.00%)
After-Hours: 20:00
BeiGene Market Cap: 20.76B for Nov. 21, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| November 20, 2024 | 20.71B |
| November 19, 2024 | 20.02B |
| November 18, 2024 | 20.01B |
| November 15, 2024 | 20.18B |
| November 14, 2024 | 20.61B |
| November 13, 2024 | 20.84B |
| November 12, 2024 | 20.65B |
| November 11, 2024 | 21.86B |
| November 08, 2024 | 21.91B |
| November 07, 2024 | 22.05B |
| November 06, 2024 | 21.61B |
| November 05, 2024 | 22.18B |
| November 04, 2024 | 22.10B |
| November 01, 2024 | 21.77B |
| October 31, 2024 | 21.53B |
| October 30, 2024 | 21.88B |
| October 29, 2024 | 23.00B |
| October 28, 2024 | 23.07B |
| October 25, 2024 | 22.60B |
| October 24, 2024 | 22.74B |
| October 23, 2024 | 23.47B |
| October 22, 2024 | 23.43B |
| October 21, 2024 | 23.35B |
| October 18, 2024 | 23.25B |
| October 17, 2024 | 22.55B |
| Date | Value |
|---|---|
| October 16, 2024 | 23.59B |
| October 15, 2024 | 23.64B |
| October 14, 2024 | 24.11B |
| October 11, 2024 | 25.07B |
| October 10, 2024 | 25.42B |
| October 09, 2024 | 25.53B |
| October 08, 2024 | 25.00B |
| October 07, 2024 | 25.81B |
| October 04, 2024 | 26.13B |
| October 03, 2024 | 24.81B |
| October 02, 2024 | 24.81B |
| October 01, 2024 | 24.53B |
| September 30, 2024 | 23.84B |
| September 27, 2024 | 23.17B |
| September 26, 2024 | 22.54B |
| September 25, 2024 | 21.93B |
| September 24, 2024 | 22.20B |
| September 23, 2024 | 21.35B |
| September 20, 2024 | 21.43B |
| September 19, 2024 | 21.07B |
| September 18, 2024 | 20.93B |
| September 17, 2024 | 20.95B |
| September 16, 2024 | 20.84B |
| September 13, 2024 | 21.06B |
| September 12, 2024 | 20.82B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
9.413B
Minimum
Mar 25 2020
37.51B
Maximum
Sep 17 2021
21.60B
Average
20.76B
Median
Market Cap Benchmarks
| Theravance Biopharma Inc | 473.06M |
| Merck & Co Inc | 252.58B |
| Bristol-Myers Squibb Co | 118.12B |
| Zai Lab Ltd | 2.762B |
| Halozyme Therapeutics Inc | 5.818B |
Market Cap Related Metrics
| PS Ratio | 6.150 |
| Price to Book Value | 6.043 |
| Price | 194.76 |
| Earnings Yield | -4.27% |